Cargando…

Clinical and Pharmacological Investigation of Myotoxicity in Sri Lankan Russell’s Viper (Daboia russelii) Envenoming

BACKGROUND: Sri Lankan Russell’s viper (Daboia russelii) envenoming is reported to cause myotoxicity and neurotoxicity, which are different to the effects of envenoming by most other populations of Russell’s vipers. This study aimed to investigate evidence of myotoxicity in Russell’s viper envenomin...

Descripción completa

Detalles Bibliográficos
Autores principales: Silva, Anjana, Johnston, Christopher, Kuruppu, Sanjaya, Kneisz, Daniela, Maduwage, Kalana, Kleifeld, Oded, Smith, A. Ian, Siribaddana, Sisira, Buckley, Nicholas A., Hodgson, Wayne C., Isbister, Geoffrey K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5135039/
https://www.ncbi.nlm.nih.gov/pubmed/27911900
http://dx.doi.org/10.1371/journal.pntd.0005172
_version_ 1782471558761021440
author Silva, Anjana
Johnston, Christopher
Kuruppu, Sanjaya
Kneisz, Daniela
Maduwage, Kalana
Kleifeld, Oded
Smith, A. Ian
Siribaddana, Sisira
Buckley, Nicholas A.
Hodgson, Wayne C.
Isbister, Geoffrey K.
author_facet Silva, Anjana
Johnston, Christopher
Kuruppu, Sanjaya
Kneisz, Daniela
Maduwage, Kalana
Kleifeld, Oded
Smith, A. Ian
Siribaddana, Sisira
Buckley, Nicholas A.
Hodgson, Wayne C.
Isbister, Geoffrey K.
author_sort Silva, Anjana
collection PubMed
description BACKGROUND: Sri Lankan Russell’s viper (Daboia russelii) envenoming is reported to cause myotoxicity and neurotoxicity, which are different to the effects of envenoming by most other populations of Russell’s vipers. This study aimed to investigate evidence of myotoxicity in Russell’s viper envenoming, response to antivenom and the toxins responsible for myotoxicity. METHODOLOGY AND FINDINGS: Clinical features of myotoxicity were assessed in authenticated Russell’s viper bite patients admitted to a Sri Lankan teaching hospital. Toxins were isolated using high-performance liquid chromatography. In-vitro myotoxicity of the venom and toxins was investigated in chick biventer nerve-muscle preparations. Of 245 enrolled patients, 177 (72.2%) had local myalgia and 173 (70.6%) had local muscle tenderness. Generalized myalgia and muscle tenderness were present in 35 (14.2%) and 29 (11.8%) patients, respectively. Thirty-seven patients had high (>300 U/l) serum creatine kinase (CK) concentrations in samples 24h post-bite (median: 666 U/l; maximum: 1066 U/l). Peak venom and 24h CK concentrations were not associated (Spearman’s correlation; p = 0.48). The 24h CK concentrations differed in patients without myotoxicity (median 58 U/l), compared to those with local (137 U/l) and generalised signs/symptoms of myotoxicity (107 U/l; p = 0.049). Venom caused concentration-dependent inhibition of direct twitches in the chick biventer cervicis nerve-muscle preparation, without completely abolishing direct twitches after 3 h even at 80 μg/ml. Indian polyvalent antivenom did not prevent in-vitro myotoxicity at recommended concentrations. Two phospholipase A(2) toxins with molecular weights of 13kDa, U1-viperitoxin-Dr1a (19.2% of venom) and U1-viperitoxin-Dr1b (22.7% of venom), concentration dependently inhibited direct twitches in the chick biventer cervicis nerve-muscle preparation. At 3 μM, U1-viperitoxin-Dr1a abolished twitches, while U1-viperitoxin-Dr1b caused 70% inhibition of twitch force after 3h. Removal of both toxins from whole venom resulted in no in-vitro myotoxicity. CONCLUSION: The study shows that myotoxicity in Sri Lankan Russell’s viper envenoming is mild and non-life threatening, and due to two PLA(2) toxins with weak myotoxic properties.
format Online
Article
Text
id pubmed-5135039
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-51350392016-12-21 Clinical and Pharmacological Investigation of Myotoxicity in Sri Lankan Russell’s Viper (Daboia russelii) Envenoming Silva, Anjana Johnston, Christopher Kuruppu, Sanjaya Kneisz, Daniela Maduwage, Kalana Kleifeld, Oded Smith, A. Ian Siribaddana, Sisira Buckley, Nicholas A. Hodgson, Wayne C. Isbister, Geoffrey K. PLoS Negl Trop Dis Research Article BACKGROUND: Sri Lankan Russell’s viper (Daboia russelii) envenoming is reported to cause myotoxicity and neurotoxicity, which are different to the effects of envenoming by most other populations of Russell’s vipers. This study aimed to investigate evidence of myotoxicity in Russell’s viper envenoming, response to antivenom and the toxins responsible for myotoxicity. METHODOLOGY AND FINDINGS: Clinical features of myotoxicity were assessed in authenticated Russell’s viper bite patients admitted to a Sri Lankan teaching hospital. Toxins were isolated using high-performance liquid chromatography. In-vitro myotoxicity of the venom and toxins was investigated in chick biventer nerve-muscle preparations. Of 245 enrolled patients, 177 (72.2%) had local myalgia and 173 (70.6%) had local muscle tenderness. Generalized myalgia and muscle tenderness were present in 35 (14.2%) and 29 (11.8%) patients, respectively. Thirty-seven patients had high (>300 U/l) serum creatine kinase (CK) concentrations in samples 24h post-bite (median: 666 U/l; maximum: 1066 U/l). Peak venom and 24h CK concentrations were not associated (Spearman’s correlation; p = 0.48). The 24h CK concentrations differed in patients without myotoxicity (median 58 U/l), compared to those with local (137 U/l) and generalised signs/symptoms of myotoxicity (107 U/l; p = 0.049). Venom caused concentration-dependent inhibition of direct twitches in the chick biventer cervicis nerve-muscle preparation, without completely abolishing direct twitches after 3 h even at 80 μg/ml. Indian polyvalent antivenom did not prevent in-vitro myotoxicity at recommended concentrations. Two phospholipase A(2) toxins with molecular weights of 13kDa, U1-viperitoxin-Dr1a (19.2% of venom) and U1-viperitoxin-Dr1b (22.7% of venom), concentration dependently inhibited direct twitches in the chick biventer cervicis nerve-muscle preparation. At 3 μM, U1-viperitoxin-Dr1a abolished twitches, while U1-viperitoxin-Dr1b caused 70% inhibition of twitch force after 3h. Removal of both toxins from whole venom resulted in no in-vitro myotoxicity. CONCLUSION: The study shows that myotoxicity in Sri Lankan Russell’s viper envenoming is mild and non-life threatening, and due to two PLA(2) toxins with weak myotoxic properties. Public Library of Science 2016-12-02 /pmc/articles/PMC5135039/ /pubmed/27911900 http://dx.doi.org/10.1371/journal.pntd.0005172 Text en © 2016 Silva et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Silva, Anjana
Johnston, Christopher
Kuruppu, Sanjaya
Kneisz, Daniela
Maduwage, Kalana
Kleifeld, Oded
Smith, A. Ian
Siribaddana, Sisira
Buckley, Nicholas A.
Hodgson, Wayne C.
Isbister, Geoffrey K.
Clinical and Pharmacological Investigation of Myotoxicity in Sri Lankan Russell’s Viper (Daboia russelii) Envenoming
title Clinical and Pharmacological Investigation of Myotoxicity in Sri Lankan Russell’s Viper (Daboia russelii) Envenoming
title_full Clinical and Pharmacological Investigation of Myotoxicity in Sri Lankan Russell’s Viper (Daboia russelii) Envenoming
title_fullStr Clinical and Pharmacological Investigation of Myotoxicity in Sri Lankan Russell’s Viper (Daboia russelii) Envenoming
title_full_unstemmed Clinical and Pharmacological Investigation of Myotoxicity in Sri Lankan Russell’s Viper (Daboia russelii) Envenoming
title_short Clinical and Pharmacological Investigation of Myotoxicity in Sri Lankan Russell’s Viper (Daboia russelii) Envenoming
title_sort clinical and pharmacological investigation of myotoxicity in sri lankan russell’s viper (daboia russelii) envenoming
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5135039/
https://www.ncbi.nlm.nih.gov/pubmed/27911900
http://dx.doi.org/10.1371/journal.pntd.0005172
work_keys_str_mv AT silvaanjana clinicalandpharmacologicalinvestigationofmyotoxicityinsrilankanrussellsviperdaboiarusseliienvenoming
AT johnstonchristopher clinicalandpharmacologicalinvestigationofmyotoxicityinsrilankanrussellsviperdaboiarusseliienvenoming
AT kuruppusanjaya clinicalandpharmacologicalinvestigationofmyotoxicityinsrilankanrussellsviperdaboiarusseliienvenoming
AT kneiszdaniela clinicalandpharmacologicalinvestigationofmyotoxicityinsrilankanrussellsviperdaboiarusseliienvenoming
AT maduwagekalana clinicalandpharmacologicalinvestigationofmyotoxicityinsrilankanrussellsviperdaboiarusseliienvenoming
AT kleifeldoded clinicalandpharmacologicalinvestigationofmyotoxicityinsrilankanrussellsviperdaboiarusseliienvenoming
AT smithaian clinicalandpharmacologicalinvestigationofmyotoxicityinsrilankanrussellsviperdaboiarusseliienvenoming
AT siribaddanasisira clinicalandpharmacologicalinvestigationofmyotoxicityinsrilankanrussellsviperdaboiarusseliienvenoming
AT buckleynicholasa clinicalandpharmacologicalinvestigationofmyotoxicityinsrilankanrussellsviperdaboiarusseliienvenoming
AT hodgsonwaynec clinicalandpharmacologicalinvestigationofmyotoxicityinsrilankanrussellsviperdaboiarusseliienvenoming
AT isbistergeoffreyk clinicalandpharmacologicalinvestigationofmyotoxicityinsrilankanrussellsviperdaboiarusseliienvenoming